IconOVir Bio
IconOVir Bio is an oncolytic Virus Therapy.
All edits
Edits on 26 Nov, 2023
Golden Au
Edits on 22 Nov, 2023
Amy Sar
Edits on 9 May, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 19 Sep, 2022
Katrina-Kay Pettitt
Edits on 12 Jul, 2022
Bhupendra Solanki
Edits made to:
Infobox (+1 properties)
Infobox
Crunchbase URL
Edits on 11 Jun, 2022
Golden AI
Edits on 6 Jun, 2022
Bhupendra Solanki
Edits made to:
Infobox (+1 properties)
Infobox
Company Operating Status
Active
Bhupendra Solanki
Edits on 20 Mar, 2022
Golden AI
Golden AI
Edits made to:
Infobox (+2/-1 properties)
Infobox
Total funding amount (USD)
154,000,000
Latest funding round amount (USD)
77,000,000
Total funding amount (USD)
77,000,000
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Investors
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Funding rounds
Edits on 22 Sep, 2021
Aleksander Holm
Edits on 5 Sep, 2021
Golden AI
Edits on 14 Jun, 2021
Erin Scherfner
Edits made to:
Infobox (+2 properties)
Description (+23 characters)
IconOVir Bio
Oncolytic Virus Therapy
Infobox
Country
Industry
Edits on 20 May, 2021
Aime Anne Nisay
Edits made to:
Timeline (+1 events) (+186 characters)
Timeline
May 20, 2021
IconOVir Bio announces preclinical proof-of-concept data for proprietary mutations designed to improve selectivity of novel oncolytic viruses, including lead product candidate ICVB-1042.
Edits on 12 May, 2021
Golden AI
Edits on 29 Mar, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Edits on 6 Jan, 2021
Golden AI
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
77,000,000
Total funding amount (USD)
154,000,000
Find more companies like IconOVir Bio
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
